Company: MDCXW
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001062993-25-008292
Chunk: 247

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-01
Form: DRS
Chunk 247
---
 between Medicus Pharma Ltd. and YA II PN, LTD. (incorporated by reference from Exhibit 1.1 to the Registrant's Current Report on Form 8-K, filed with the SEC on February 11, 2025)      |
| 21.1  | List of Subsidiaries of Medicus Pharma Ltd. (incorporated by reference from Exhibit 21.1 to the Registrant's Registration Statement on Form F-1, filed with the SEC on May 29, 2024)                                                                              |
| 23.1* | Consent of EisnerAmper LLP                                                                                                                                                                                                                                        |
| 23.2* | Consent of MNP LLP                                                                                                                                                                                                                                                |
| 23.3  | Form of Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                    |
| 24.1* | Powers of Attorney (included in the signature page to this Registration Statement)                                                                                                                                                                                |
| 107*  | Filing fee table                                                                                                                                                                                                                                                  |

*To be filed by amendment.

+Indicates a management contract or compensatory plan.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

† Certain private or confidential information (as indicated therein) have been redacted pursuant to Item 601(a)(6) of Regulation S-K.

<div align='center'>II-6</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in W. Conshohocken, Pennsylvania
this day of , 2025.

| MEDICUS PHARMA LTD. |                                                       |
| By:                 |                                                       |
|                     | Name: Dr. Raza Bokhari                                
 Title: Executive Chairman and Chief Executive Officer |

<div align='center'>II-7</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

<div